InnoCare Pharma Limited (HKG:9969)

InnoCare Pharma Revenue

InnoCare Pharma had revenue of 350.17M CNY in the quarter ending June 30, 2025, with 37.91% growth. This brings the company's revenue in the last twelve months to 1.32B, up 69.22% year-over-year. In the year 2024, InnoCare Pharma had annual revenue of 1.01B with 36.68% growth.

• Revenue (ttm): 1.32B CNY
• Revenue Growth: +69.22%
• P/S Ratio: 23.76
• Revenue / Employee: 1.41M CNY
• Employees: 939
• Market Cap: 34.40B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.01B	270.91M	36.68%
Dec 31, 2023	738.54M	113.13M	18.09%
Dec 31, 2022	625.40M	-417.63M	-40.04%
Dec 31, 2021	1.04B	1.04B	76,368.70%
Dec 31, 2020	1.36M	117.00K	9.38%